These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11523910)

  • 1. The influence of long-term different diabetic therapies on plasma leptin in type 2 diabetic subjects.
    Huang CC; Lin JD; Chang HY
    Endocr J; 2001 Jun; 48(3):377-83. PubMed ID: 11523910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects.
    Ozata M; Gungor D; Turan M; Ozisik G; Bingol N; Ozgurtas T; Ozdemir IC
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3659-64. PubMed ID: 11502793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass.
    Fischer S; Hanefeld M; Haffner SM; Fusch C; Schwanebeck U; Köhler C; Fücker K; Julius U
    Acta Diabetol; 2002 Sep; 39(3):105-10. PubMed ID: 12357293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of regional adiposity to serum leptin level in nonobese Japanese type 2 diabetic male patients.
    Okumura T; Taniguchi A; Nagasaka S; Sakai M; Fukushima M; Kuroe A; Yoshii S; Nakamura T; Ogura M; Atarashi T; Nishida S; Nakai Y
    Diabetes Metab; 2003 Feb; 29(1):15-8. PubMed ID: 12629443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin and body fat in type 2 diabetes and monodrug therapy.
    Sivitz WI; Wayson SM; Bayless ML; Larson LF; Sinkey C; Bar RS; Haynes WG
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1543-53. PubMed ID: 12679437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of endogenous insulin secretion and mode of therapy with body fat and serum leptin levels in diabetic subjects.
    Nagasaka S; Ishikawa S; Nakamura T; Kawakami A; Rokkaku K; Hayashi H; Kusaka I; Higashiyama M; Saito T
    Metabolism; 1998 Nov; 47(11):1391-6. PubMed ID: 9826219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-stimulated increase in serum leptin levels precedes and correlates with weight gain during insulin therapy in type 2 diabetes.
    Aas AM; Hanssen KF; Berg JP; Thorsby PM; Birkeland KI
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2900-6. PubMed ID: 19509109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin and body fat distribution have no direct effect on plasma leptin levels in obese Caucasian women with and without type 2 diabetes mellitus.
    Bertin E; Rich N; Schneider N; Larbre H; Marcus C; Durlach V; Leutenegger M
    Diabetes Metab; 1998 Jun; 24(3):229-34. PubMed ID: 9690055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study in the relationships between leptin, insulin, and body fat in Asian subjects.
    Ho SC; Tai ES; Eng PH; Ramli A; Tan CE; Fok AC
    Int J Obes Relat Metab Disord; 1999 Mar; 23(3):246-52. PubMed ID: 10193869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preperitoneal fat deposition estimated by ultrasonography in patients with non-insulin-dependent diabetes mellitus.
    Tayama K; Inukai T; Shimomura Y
    Diabetes Res Clin Pract; 1999 Jan; 43(1):49-58. PubMed ID: 10199588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of diabetes in influencing leptin concentration in elderly overweight patients.
    Passaro A; Calzoni F; Zamboni PF; Manservigi D; Alberti L; Dalla Nora E; Fellin R; Solini A
    Eur J Endocrinol; 2001 Aug; 145(2):173-9. PubMed ID: 11454513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble E-selectin, leptin, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients.
    Taniguchi A; Fukushima M; Nakai Y; Kuroe A; Yamano G; Yanagawa T; Ohgushi M; Ohya M; Yoshii S; Taki Y; Seino Y
    Metabolism; 2005 Mar; 54(3):376-80. PubMed ID: 15736116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y; Mahankali A; Wajcberg E; Bajaj M; Mandarino LJ; DeFronzo RA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4312-9. PubMed ID: 15356026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat oxidation, body composition and insulin sensitivity in diabetic and normoglycaemic obese adults 5 years after weight loss.
    Poynten AM; Markovic TP; Maclean EL; Furler SM; Freund J; Chisholm DJ; Campbell LV
    Int J Obes Relat Metab Disord; 2003 Oct; 27(10):1212-8. PubMed ID: 14513069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of exercise training on serum leptin levels in type 2 diabetic patients.
    Ishii T; Yamakita T; Yamagami K; Yamamoto T; Miyamoto M; Kawasaki K; Hosoi M; Yoshioka K; Sato T; Tanaka S; Fujii S
    Metabolism; 2001 Oct; 50(10):1136-40. PubMed ID: 11586483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Study of Effects of Pioglitazone and Rosiglitazone on Various Parameters in Patients of Type-2 Diabetes Mellitus with Special Reference to Lipid Profile.
    Sharma SK; Verma SH
    J Assoc Physicians India; 2016 Sep; 64(9):24-28. PubMed ID: 27762511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The degree of hyperinsulinemia and impaired glucose tolerance predicts plasma leptin concentrations in women only: a new exploratory paradigm.
    Panarotto D; Ardilouze JL; Tessier D; Maheux P
    Metabolism; 2000 Aug; 49(8):1055-62. PubMed ID: 10954026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy.
    Putz DM; Goldner WS; Bar RS; Haynes WG; Sivitz WI
    Metabolism; 2004 Nov; 53(11):1454-61. PubMed ID: 15536601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.